Wang Jian,Co-founder and Chairman of BGI Group DNBSEQ Eseries, the modular "digital biolab" series for use with the sequencing system, and a new single "cell" MGI’s new tools can be customized or upgraded according to user needs, providing an ideal overall solution for the industry. The whole set of equipment is compact and portable. The desktop system is less than 0.1 square meters in size. At the same time, the solution is highly automated, with manual steps of less than 10 minutes for ...

With the continuous improvement of sample size and sample processing quality standards, automated database construction has gradually become the mainstream. MGISP-960 is a high-throughput automated sample preparation system independently developed by MGI, which can fully automate 8~96 samples at a time. In addition to supporting a variety of MGI series of kits, it is now available to adapt to five high-throughput sequencing sample preparation kits from five third-party brands. First, flexible c...

On October 16, 2019, the annual meeting of the American Society of Human Genetics (ASHG 2019) was held in Houston. At the meeting, MGI made its revolutionary proprietary sequencing technology CoolMPSTM test results, indicating that the chemical method of CoolMPSTM produced data on the DNBSEQTM sequencing platform is comparable to the existing platform. MGI said at the meeting that the early research results of CoolMPSTM technology are accurate, reproducible and cost-effective, and will lea...

HOUSTON, Oct. 17, 2019 -- MGI, a subsidiary of global genomics leader BGI Group, said early research results from its revolutionary CoolMPS proprietary sequencing technology performed with high accuracy, reproducibility and cost effectiveness, leading the way toward more efficient and accurate Massively Parallel Sequencing (MPS). MGI also reported that its DNBSEQ-T7 genetic sequencer, the world's most powerful, was successfully delivered to multiple customers in China. At the American Society o...

Q: The development of sequencing technology is changing with each passing day. Can you tell us about the progress we have made in recent years? A: In the past few years, high-throughput large-scale parallel sequencing technology has developed rapidly. The DNBSEQTM sequencing technology represented by MGI is particularly prominent. In the past few years, our technological progress has mainly been reflected in the detection methodology and library preparation methods, learning the production tech...

On October 16, 2019, Shenzhen MGI Technology Co., Ltd. won Award of Biotechnology Innovation Enterprise of the Guangdong, Hong Kong and Macau Greater Bay Area. The event was hosted by China Venture Industry Research Institute and KPMG China, and was hosted by Guangdong Medical Valley. The Greater Bay Biotechnology Innovation and Development Summit was also held on the same day. In addition, the event site also released the "Top 50 Innovation Reports of Biotech Enterprises in Guangdong, Hong Kon...